Literature DB >> 20511001

Are we any closer to combating Ebola infections?

Heinz Feldmann1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20511001      PMCID: PMC3398603          DOI: 10.1016/S0140-6736(10)60597-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

Review 1.  Experimental therapy of filovirus infections.

Authors:  Mike Bray; Jason Paragas
Journal:  Antiviral Res       Date:  2002-04       Impact factor: 5.970

Review 2.  Therapy and prophylaxis of Ebola virus infections.

Authors:  Heinz Feldmann; Steven M Jones; Hans-Joachim Schnittler; Thomas Geisbert
Journal:  Curr Opin Investig Drugs       Date:  2005-08

3.  Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.

Authors:  Thomas W Geisbert; Lisa E Hensley; Peter B Jahrling; Tom Larsen; Joan B Geisbert; Jason Paragas; Howard A Young; Terry M Fredeking; William E Rote; George P Vlasuk
Journal:  Lancet       Date:  2003-12-13       Impact factor: 79.321

4.  VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice.

Authors:  Sven Enterlein; Kelly L Warfield; Dana L Swenson; David A Stein; Jeffery L Smith; C Scott Gamble; Andrew D Kroeker; Patrick L Iversen; Sina Bavari; Elke Mühlberger
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

Review 5.  The ecology of Ebola virus.

Authors:  Allison Groseth; Heinz Feldmann; James E Strong
Journal:  Trends Microbiol       Date:  2007-08-15       Impact factor: 17.079

6.  Evaluation in nonhuman primates of vaccines against Ebola virus.

Authors:  Thomas W Geisbert; Peter Pushko; Kevin Anderson; Jonathan Smith; Kelly J Davis; Peter B Jahrling
Journal:  Emerg Infect Dis       Date:  2002-05       Impact factor: 6.883

7.  Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.

Authors:  Kelly L Warfield; Dana L Swenson; Gene G Olinger; Donald K Nichols; William D Pratt; Robert Blouch; David A Stein; M Javad Aman; Patrick L Iversen; Sina Bavari
Journal:  PLoS Pathog       Date:  2006-01-13       Impact factor: 6.823

8.  Effective post-exposure treatment of Ebola infection.

Authors:  Heinz Feldmann; Steven M Jones; Kathleen M Daddario-DiCaprio; Joan B Geisbert; Ute Ströher; Allen Grolla; Mike Bray; Elizabeth A Fritz; Lisa Fernando; Friederike Feldmann; Lisa E Hensley; Thomas W Geisbert
Journal:  PLoS Pathog       Date:  2007-01       Impact factor: 6.823

9.  Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference.

Authors:  Thomas W Geisbert; Lisa E Hensley; Elliott Kagan; Erik Zhaoying Yu; Joan B Geisbert; Kathleen Daddario-DiCaprio; Elizabeth A Fritz; Peter B Jahrling; Kevin McClintock; Janet R Phelps; Amy C H Lee; Adam Judge; Lloyd B Jeffs; Ian MacLachlan
Journal:  J Infect Dis       Date:  2006-05-10       Impact factor: 5.226

10.  Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study.

Authors:  Thomas W Geisbert; Amy C H Lee; Marjorie Robbins; Joan B Geisbert; Anna N Honko; Vandana Sood; Joshua C Johnson; Susan de Jong; Iran Tavakoli; Adam Judge; Lisa E Hensley; Ian Maclachlan
Journal:  Lancet       Date:  2010-05-29       Impact factor: 79.321

View more
  5 in total

Review 1.  Molecular pathogenesis of viral hemorrhagic fever.

Authors:  Christopher F Basler
Journal:  Semin Immunopathol       Date:  2017-05-29       Impact factor: 9.623

Review 2.  Ebola and Marburg hemorrhagic fevers: neglected tropical diseases?

Authors:  Adam MacNeil; Pierre E Rollin
Journal:  PLoS Negl Trop Dis       Date:  2012-06-26

3.  Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories.

Authors:  N Wurtz; A Papa; M Hukic; A Di Caro; I Leparc-Goffart; E Leroy; M P Landini; Z Sekeyova; J S Dumler; D Bădescu; N Busquets; A Calistri; C Parolin; G Palù; I Christova; M Maurin; B La Scola; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-27       Impact factor: 3.267

4.  Controlling Ebola: what we can learn from China's 1911 battle against the pneumonic plague in Manchuria.

Authors:  He Liu; Mingli Jiao; Siqi Zhao; Kai Xing; Ye Li; Ning Ning; Libo Liang; Qunhong Wu; Yanhua Hao
Journal:  Int J Infect Dis       Date:  2015-02-24       Impact factor: 3.623

Review 5.  Ebola hemorrhagic fever outbreaks: strategies for effective epidemic management, containment and control.

Authors:  Gerald Amandu Matua; Dirk Mostert Van der Wal; Rozzano C Locsin
Journal:  Braz J Infect Dis       Date:  2015-04-17       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.